Integrated Genetic and Functional Analysis of the Influence of Menstrual Hygiene Products on Female Health
Luna
1 other identifier
interventional
100
1 country
1
Brief Summary
Women's reproductive health has attracted increasing attention in recent years, including in the field of microbiology. Vaginal infections, such as vulvovaginal candidiasis, bacterial vaginosis and aerobic vaginitis, are common and a huge burden on our society. The vaginal microbiome is important in the prevention of these infections, in fertility and for healthy pregnancies. The composition, and therefore the 'health' of the vaginal microbiome, is influenced by many internal and external factors, including intimate health. However, it is not yet known how intimate health, and specifically the use of menstrual hygiene products, affects the microbiome and women's intimate comfort and health. In this study, the researchers aim to understand the influence of 5 menstrual hygiene products (tampon, menstrual cup, menstrual pad and 2 types of menstrual underwear) on women's intimate health (n = 100). First, this will be evaluated at the microbiome level, focusing on the female intimate microbiome, consisting of the skin in the groin, vulvar and vaginal microbiome. These sites are all closely linked and are affected in vaginal infections or by contact with menstrual hygiene products. Second, in addition to the direct impact on the microbiome, the impact on the participant's immune system will be evaluated, as some well-known menstrual hygiene products can cause irritation and inflammation. As a third goal, participants will assess the comfort and usability of each menstrual hygiene product and provide data on their lifestyle and other factors that may influence our results. The main goal is to investigate and define the impact of menstrual hygiene products on women's intimate health so that women can make an informed choice. In a first phase participants (n = 1500) will fill in a survey containing questions on general health, lifestyle and menstrual health. Based on these responses a selection of 100 participants will be made by the researchers to participate in the intervention trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 13, 2024
CompletedFirst Posted
Study publicly available on registry
July 25, 2024
CompletedStudy Start
First participant enrolled
August 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2025
CompletedJuly 25, 2024
January 1, 2024
6 months
May 13, 2024
July 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Beta diversity of the vaginal microbiome
This measure describes the taxonomic diversity between samples, a higher diversity is associated with a less healthy vaginal microbiome. Beta diversity within a participant over all products will be calculated as a stability measure. This will be defined for each participant comparing the baseline samples (right before menstruation) to the sample during and after menstruation. Comparison will be made between different menstrual hygiene products.
Each month for 3 samplepoints until study completion, an average of 6 months
Secondary Outcomes (4)
relative abundance of eigentaxa
Each month for 3 samplepoints until study completion, an average of 6 months
comfort and ease of use
Periodically, after menstruation once a month.
alfa diversity of the vaginal microbiome
Each month for 3 samplepoints until study completion, an average of 6 months
both alfa and beta diversity of the vulvar and groin skin microbiome
Each month for 3 samplepoints until study completion, an average of 6 months
Study Arms (2)
Combination pill
EXPERIMENTALThis arm ( n = 50) is selected based on their contraception use, under the combination pill your menstruation and composition of menstrual blood is altered. In this arm all participants will wear all 5 menstrual products, 1 product per menstruation. The order of products will be randomized over this arm.
No-hormonal contracteption
EXPERIMENTALThis arm (n = 50) is selected based on the use of no hormonal contraception, to investigate a natural menstrual cycle. In this arm all participants will wear all 5 menstrual products, 1 product per menstruation. The order of products will be randomized over this arm.
Interventions
The influence on the intimate health of each product will be evaluated. As you can't not use a menstrual product during menstruation, no control group is included
Eligibility Criteria
You may qualify if:
- female
- contraception: combination pill with stop week or no hormonal contraception
- premenopausal
- Dutch-speaking living in Belgium
- regular menstrual cycle (if no hormonal contraception)
You may not qualify if:
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Antwerplead
- Universiteit Antwerpencollaborator
- Research Foundation Flanderscollaborator
Study Sites (1)
University of Antwerp
Antwerp, 2020, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- As the intervention is the use of a menstrual product, no masking is possible.
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 13, 2024
First Posted
July 25, 2024
Study Start
August 1, 2024
Primary Completion
February 1, 2025
Study Completion
October 31, 2025
Last Updated
July 25, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share